ALK and non-small cell lung carcinoma: Approximately 85% of lung cancer cases are characterized as non-small cell lung cancer (NSCLC) cases [2] and anaplastic lymphoma kinase (ALK) positive is therein non-negligible, occurring in 2 to 7% of all NSCLC [3].